Copycat Ozempic, Mounjaro proliferate even in postshortage era
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, unapproved drugs to reach consumers. When the Food and Drug Administration (FDA) adds a drug to its official shortage list, compounding pharmacies can sell their own versions…
